Table 3 Demographics of dogs enrolled as veterinary patients and included in the safety-evaluable population for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
Demographic | US heartworm prevention field study | |
|---|---|---|
Credelio Plus (n = 159) | Milbemycin oxime + lufenuron (n = 158) | |
Purebred (n) (%) | 111 (69.8) | 76 (48.1) |
Crossbred/mongrel (n) (%) | 48 (30.2) | 82 (51.9) |
Age, mean (months) | 48.6 | 46.8 |
Age, range (months) | 2.0–158.0 | 2.0–165.0 |
Age group < 12 months (n) (%) | 52 (32.7) | 48 (30.4) |
Age group ≥ 12 months (n) (%) | 107 (67.3) | 110 (69.6) |
Male (n) (%) | 79 (49.7) | 65 (41.1) |
Female (n) (%) | 80 (50.3) | 93 (58.9) |
Body weight, mean (kg) | 16.4 | 18.0 |
Body weight, range (kg) | 2.1–50.7 | 2.0–61.1 |